PI
The startup operates a digital pathology platform that utilizes computational microscopy and artificial intelligence to analyze tissue samples with high speed and accuracy. This technology enables healthcare providers to achieve earlier and more precise diagnoses, ultimately improving patient outcomes and reducing the time required for diagnostic processes.
Updated 3 months ago
Funding
$19.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a digital pathology platform that utilizes computational microscopy and artificial intelligence to analyze tissue samples with high speed and accuracy. This technology enables healthcare providers to achieve earlier and more precise diagnoses, ultimately improving patient outcomes and reducing the time required for diagnostic processes.